Profile
| Metric | Value |
|---|---|
| Full Name | Scholar Rock Holding Corporation |
| Ticker | NASDAQ: SRRK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | scholarrock.com |
| Employees | 128 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $41.31 | |
| Price, 1D Change | -3.39% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.29 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$2.47 | |
| EPS, 1Y Change | -24.02% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.47 | |
| EPS Estimate | -$3.38 | |
| EPS Est. Change | -37.08% | |
| Revenue | $0.00 | |
| Revenue Estimate | $181.82K | |
| Revenue Est. Change | - | |
| Current Price | $41.31 | |
| Price Target | - | $48.50 |
| Price Tgt. Change | - | +17.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.95 | -$1.99 | -2.01% | |
| -$2.48 | -$2.47 | +0.37% | |
| -$3.38 | N/A | -37.08% | |
| -$3.01 | N/A | -21.91% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $181.82K | N/A | - | |
| $37.58M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -3.62% | |
| Price, 3Y | +341.35% | |
| Market Cap, 1Y | +4.79% | |
| Market Cap, 3Y | +771.27% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | -100.00% | |
| EPS, 1Y | -24.02% | |
| EPS, 3Y | +31.29% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $41.31 | |
| SMA 200 | $34.71 | |
| SMA 200 vs Price | -15.97% | |
| SMA 50 | $39.04 | |
| SMA 50 vs Price | -5.49% | |
| Beta | 1.29 | |
| ATR | $1.90 | |
| 14-Day RSI | 43.52 | |
| 10-Day Volatility | 34.11% | |
| 1-Year Volatility | 68.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$2.47 | |
| Gross Profit | -$1.94M | |
| Gross Margin | - | |
| Operating Profit | -$252.05M | |
| Operating Margin | - | |
| Net Income | -$246.29M | |
| Net Margin | - | |
| EBITDA | -$250.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.18 | |
| Current Ratio | 9.61 | |
| Quick Ratio | 9.61 | |
| - | ||
| F-Score | - | |
| Altman Z-Score | 20.34 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 17.20 | |
| EV/EBITDA | -10.97 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $368.63M | |
| Cash & Equivalents | $177.88M | |
| Total Assets | $474.92M | |
| Current Assets | $451.17M | |
| Total Liabilities | $106.29M | |
| Current Liabilities | $46.94M | |
| Total Debt | $65.13M | |
| Short Term Debt | $5.77M | |
| Accounts Payable | $10.10M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $252.05M | |
| Operating Expenses | $252.05M | |
| Cost Of Goods Sold | $1.94M | |
| SG&A | $67.50M | |
| D&A | $1.94M | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$200.95M | |
| CFI | -$76.06M | |
| CFF | $353.03M | |
| Capex | $98.00K | |
| Free Cash Flow | -$201.05M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Wolfe Research | ||
| JP Morgan | → | |
| Barclays | → | |
| Truist Securities | → | |
| B of A Securities | ||
| Piper Sandler | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Barclays |
Analyst sentiment
Institutional ownership
Screeners with SRRK
Data Sources & References
- SRRK Official Website www.scholarrock.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1727196/000110465925111935/0001104659-25-111935-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1727196/000155837025001682/0001558370-25-001682-index.htm
- SRRK Profile on Yahoo Finance finance.yahoo.com/quote/SRRK
- SRRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/srrk
FAQ
What is the ticker symbol for Scholar Rock Holding Corporation?
The ticker symbol for Scholar Rock Holding Corporation is NASDAQ:SRRK
Does Scholar Rock Holding Corporation pay dividends?
No, Scholar Rock Holding Corporation does not pay dividends
What sector is Scholar Rock Holding Corporation in?
Scholar Rock Holding Corporation is in the Healthcare sector
What industry is Scholar Rock Holding Corporation in?
Scholar Rock Holding Corporation is in the Biotechnology industry
What country is Scholar Rock Holding Corporation based in?
Scholar Rock Holding Corporation is headquartered in United States
When did Scholar Rock Holding Corporation go public?
Scholar Rock Holding Corporation initial public offering (IPO) was on May 25, 2018
Is Scholar Rock Holding Corporation in the S&P 500?
No, Scholar Rock Holding Corporation is not included in the S&P 500 index
Is Scholar Rock Holding Corporation in the NASDAQ 100?
No, Scholar Rock Holding Corporation is not included in the NASDAQ 100 index
Is Scholar Rock Holding Corporation in the Dow Jones?
No, Scholar Rock Holding Corporation is not included in the Dow Jones index
When was Scholar Rock Holding Corporation last earnings report?
Scholar Rock Holding Corporation's most recent earnings report was on November 14, 2025
When does Scholar Rock Holding Corporation report earnings?
The next expected earnings date for Scholar Rock Holding Corporation is February 26, 2026